Literature DB >> 19803758

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.

Markus Rose1, Stefan Zielen.   

Abstract

In 2000/2001, a 7-valent pneumococcal conjugate vaccine (PCV-7) was licensed in Europe. During the following years and based on positive experiences from the USA, more and more European countries recommended routine immunization of infants and of children at an increased risk for invasive pneumococcal disease. Many studies documented the impact on invasive pneumococcal disease, but also on noninvasive pneumococcal disease. This review summarizes current evidence on the population-based impact of infant immunization programs in Europe.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19803758     DOI： 10.1586/erv.09.78

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


  18 in total

1.  A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era.

Authors:  Chiara Mameli; Valentina Fabiano; Laura Daprai; Giorgio Bedogni; Marino Faccini; Maria Laura Garlaschi; Francesca Penagini; Dario Dilillo; Erminio Torresani; Maria Gramegna; Gian Vincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation.

Authors:  Filippo Ansaldi; Daniela de Florentiis; Paola Canepa; Antonella Ceravolo; Emanuela Rappazzo; Rocco Iudici; Mariano Martini; Gerardo Botti; Andrea Orsi; Giancarlo Icardi; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

3.  Respiratory infection and otitis media visits in relation to pneumococcal conjugate vaccine use in Saskatchewan.

Authors:  Ngoc-Hang Khuc; Ben Tan; Rosalie Tuchscherer; Nigel Sb Rawson; Philippe De Wals
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide.

Authors:  Mehmet Ceyhan; Nezahat Gurler; Akgun Yaman; Candan Ozturk; Lutfiye Oksuz; Sengul Ozkan; Melike Keser; Nuran Salman; Emre Alhan; Duygu Esel; Meral Gultekin; Yildiz Camcioglu; Mustafa Gul; Yelda Sorguc; Sohret Aydemir; Murat Gunaydin; Yusuf Yakupogullari; Ahmet Kizirgil
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

5.  Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Authors:  Il Gyu Kong; Ayuko Sato; Yoshikazu Yuki; Tomonori Nochi; Haruko Takahashi; Shinichi Sawada; Mio Mejima; Shiho Kurokawa; Kazunari Okada; Shintaro Sato; David E Briles; Jun Kunisawa; Yusuke Inoue; Masafumi Yamamoto; Kazunari Akiyoshi; Hiroshi Kiyono
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

6.  Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands.

Authors:  Judith Spijkerman; Elske J M van Gils; Reinier H Veenhoven; Eelko Hak; Ed P F Yzerman; Arie van der Ende; Alienke J Wijmenga-Monsuur; Germie P J M van den Dobbelsteen; Elisabeth A M Sanders
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

Review 7.  Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review.

Authors:  Ying Chen; Wei Deng; Song-Mei Wang; Qi-Mei Mo; Huan Jia; Qun Wang; Song-Guang Li; Xiang Li; Bao-Dong Yao; Cheng-Jun Liu; Yi-Qiang Zhan; Chen Ji; Anna Lena Lopez; Xuan-Yi Wang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis.

Authors:  Judith Spijkerman; Sabine M P J Prevaes; Elske J M van Gils; Reinier H Veenhoven; Jacob P Bruin; Debby Bogaert; Alienke J Wijmenga-Monsuur; Germie P J M van den Dobbelsteen; Elisabeth A M Sanders
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

9.  Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants.

Authors:  Simon Rückinger; Mark van der Linden; Rüdiger von Kries
Journal:  BMC Infect Dis       Date:  2010-01-19       Impact factor: 3.090

10.  Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013.

Authors:  Songyin Huang; Xiaoqiang Liu; Weisi Lao; Suhua Zeng; Huiqi Liang; Rihui Zhong; Xinlu Dai; Xiquan Wu; Hongyu Li; Yandan Yao
Journal:  BMC Infect Dis       Date:  2015-08-05       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.